reference/36007188

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36007188

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	0041-008X
pageRange	116568-
publicationName	Toxicology and Applied Pharmacology
startingPage	116568
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_efbf2c5aefa2dba41b3d3273e97e3c79 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1127f510a307045ce19c80d510284a60 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_717cabf92e5a9ff0e95176e496c89e15 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5607dd1667a3b2bb14dbfa61f83de740 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_bd33c1ae911cdb9c9ed22c174c636638 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_50c4720ef64606fffe1ce62ca77e9629 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5d3914447cfc241a0aedc83f265c67ee
bibliographicCitation	Lin JC, Liu TP, Chen YB, Huang TS, Chen TY, Yang PM. Inhibition of CDK9 exhibits anticancer activity in hepatocellular carcinoma cells via targeting ribonucleotide reductase. Toxicol Appl Pharmacol. 2023 Jul 15;471():116568. doi: 10.1016/j.taap.2023.116568. PMID: 37245555.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3020e179c616959fe9baeaab6121cf7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_249d9fccdb51c9464384cdf3b5f8afb2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2089538ffcf357a818d092669ae51c86 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f06b0e6548a50ea6d3828457441e9449 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e1e72dd69de50ecfdcbd39d1df1035b0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83060006fb6caef43d2bea0ba7436a6d
date	2023-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/37245555 https://doi.org/10.1016/j.taap.2023.116568
isPartOf	https://portal.issn.org/resource/ISSN/0041-008X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7769
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Inhibition of CDK9 exhibits anticancer activity in hepatocellular carcinoma cells via targeting ribonucleotide reductase
discusses	http://id.nlm.nih.gov/mesh/M0442145 http://id.nlm.nih.gov/mesh/M000596960 http://id.nlm.nih.gov/mesh/M0018275 http://id.nlm.nih.gov/mesh/M0019075 http://id.nlm.nih.gov/mesh/M0230514
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25104564 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_df6a966bb0eee33d98c04cffe415be72 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1c4b72abd3d7b84d3d2a0db7c5a371d2 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.17.4.2 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8908d9f016f678ac2f17eeac90bb5212 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.25.1 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7998

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53787461 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID441532649

Total number of triples: 44.